top of page
The
System
Novel technology to continuously monitor a mother’s risk for postpartum hemorrhage during Labor and Delivery, saving lives, reducing maternal complications, and cutting obstetrics costs.
We improve risk prediction up to 10x beyond the current standard of care
Vasowatch conducted an observational study on a diverse population of 525 women in Labor and Delivery at a large urban Pennsylvania Hospital. We compared the hospital's expert-based survey risk assessment administered at admission to that of the Vasowatch algorithm. Here are the results:
Competitive Landscape
Improved risk prediction enables timely & cost saving treatment
Dose of a uterotonic medication
$10-$500
Blood transfusion
>$3000
Vasowatch System 1.0
Completed 07/24
Sibel Health sensors
510(K)
SaMD
De Novo
Dashboards
Bedside + Nurses’ Station
bottom of page